Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
265.00    5.00 (1.92%)
Bid:
251.00
Ask:
257.00
Spread: 6.00 (2.39%)
Market Cap: £237.32m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

5 Nov 2008 07:00

RNS Number : 4573H
Wilmington Group Plc
05 November 2008
Β 

ο»Ώ

5 November 2008

WILMINGTON GROUP PLC

INTERIM MANAGEMENT STATEMENT

At today's Annual General Meeting of Wilmington Group plc, David Summers, Chairman, will makeΒ reference toΒ the following statement regarding the financial position and current trading performance:

Trading performance in the three months to 30 September 2008, the first quarter of our financial year, was broadly in line with the board's expectationsΒ despite a deteriorating economic backdrop. Underlying revenue from continuing operations*Β was 4% ahead of the same period in the prior year.

Adjusted profitsΒ from continuing operations**Β were ahead of the prior year.

Since we announced our results for the year ended 30 June 2008,Β the economic outlook has deteriorated. ConsequentlyΒ we felt it was appropriate to initiateΒ aΒ thoroughΒ reviewΒ across the Wilmington GroupΒ to examine how we canΒ proactively maximise productivity and marginsΒ and, where appropriate, reduce our cost base.

In addition,Β the boardΒ hadΒ decidedΒ to sellΒ the music information business Muze and our HPCi business, which published the magazines "Soap, Perfumery and Cosmetics", "Manufacturing Chemist" and "CleanroomΒ Technology"Β whichΒ were not core to our strategy of serving the information and training requirements of professional markets.

Following these disposals we haveΒ reorganisedΒ the Wilmington Business Information division and consolidated the management ofΒ its assetsΒ with the Waterlow Legal and Regulatory division. This creates a professionalΒ informationΒ businessΒ thatΒ accounts for approximately 47% of Wilmington Group turnover and contributes nearly 60% of Group operating profits before central overheads.

A number ofΒ specificΒ cost and staff savings have been identified across the Group. As a result of this action we have created a more effective operational structure. However,Β non-recurring costs of approximately Β£700kΒ will beΒ incurred as a result of the proposed changes.

We announced on 28 July 2008 that the company had received an approach which subsequently did not result in an offer being made for the company. DuringΒ theΒ first quarter the company incurred approximately Β£600kΒ of abortive transaction costs.

Outlook:

We expect trading conditions toΒ remainΒ challenging.

Nevertheless, weΒ are confident that our publishingΒ and informationΒ businesses are robust andΒ should performΒ in line with the prior year.

Whilst many of our training businesses are underpinned by professional regulations, discretionary expenditureΒ by our clientsΒ is under pressure. Towards the end of our first quarter we have seenΒ aΒ reduction inΒ someΒ course bookings on a like for like basis;Β asΒ indicatedΒ the company isΒ implementing a cost reduction programme to align its cost base with current market conditions and our outlook for 2009. The reduction in course bookings is partiallyΒ mitigated by the Matchett Group, which has delivered its anticipated contribution in our first quarter when the bulk of its profits for the financial year are made. We also expect that our investment inΒ SingaporeΒ will reduce this financial year and anticipate a modest net profit fromΒ Singapore.Β 

It is always difficult toΒ predictΒ the outcome so early in the year and in these very uncertain times it is clearly even more problematic. However, given the cost savings being implemented and the momentum from recent acquisitions the Board currently expects the Group overall to report underlying performance from continuing operations marginally ahead of last year.

We remain a cash generative business with a modest level of gearing and haveΒ committed bank facilities until 2012 that will enable us to continue to underpin the development of our business with further bolt on acquisitions. Our business is resilient with strong management teams which will enable the company to continue to grow and to grasp opportunities as they arise.

David Summers

Chairman

5 November 2008

* ExcludesΒ revenue contribution from acquisitions (Matchett and APIS) and revenue contribution from disposals (Muze andΒ HPCi ).

** Pre-exceptional items and excluding any earnings contribution from disposals (Muze andΒ HPCi ).

Β - Ends -Β 

Enquiries:

Wilmington Group PLC

Charles Brady, Chief Executive 0207 422 6800

Weber Shandwick Financial

Nick Oborne /Β Louise Robson / Clare Perks 0207 067 0700

Numis Securities

James Serjeant 0207 260 1309

RBSΒ Hoare GovettΒ 

Sara Hale 0207 678 8000

Notes to Editors

Wilmington Group plc is one of the UK's leading providers of information and training for professional business markets. The Group provides training, arranges industry events and publishes magazines, directories, databases and special reports focused primarily on professional markets. Capitalised at approximately Β£120 million, Wilmington floated on the London Stock Exchange in 1995.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSUUGWCGUPRGRC
Date   Source Headline
19th Mar 20184:18 pmRNSBoard Change - Correction
19th Mar 201811:34 amRNSHolding(s) in Company
16th Mar 20181:06 pmRNSBoard Change
15th Mar 20183:36 pmRNSHolding(s) in Company
2nd Mar 20182:13 pmRNSDirector/PDMR Shareholding
1st Mar 20189:00 amRNSVoting Rights and Capital
26th Feb 20188:34 amRNSDirector/PDMR Shareholding
22nd Feb 20183:49 pmRNSHolding(s) in Company
22nd Feb 20187:00 amRNSInterim Results
22nd Feb 20187:00 amRNSAppointment of Martin Morgan as Chairman
14th Feb 20182:50 pmRNSHolding(s) in Company
1st Feb 20189:10 amRNSHolding(s) in Company
1st Feb 20189:00 amRNSVoting Rights and Capital
4th Jan 20187:00 amRNSAcquisition of Interactive Medica
2nd Jan 20189:00 amRNSVoting Rights and Capital
18th Dec 20174:43 pmRNSNotification of Interim Results
1st Dec 20177:00 amRNSVoting Rights and Capital
29th Nov 20177:00 amRNSAppointment of new Chief Financial Officer
23rd Nov 201710:34 amRNSDirector/PDMR Shareholding
2nd Nov 20172:43 pmRNSResult of AGM
2nd Nov 20177:00 amRNSAGM and Q1 Trading Update
1st Nov 20179:12 amRNSVoting Rights and Capital
6th Oct 20175:58 pmRNSHolding(s) in Company
5th Oct 20173:45 pmRNSHolding(s) in Company
5th Oct 20173:44 pmRNSHolding(s) in Company
2nd Oct 20172:49 pmRNSVoting Rights and Capital
29th Sep 20179:27 amRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSProposed Board Change
21st Sep 20171:47 pmRNSDirector/PDMR Shareholding
20th Sep 201711:50 amRNSShare Awards
18th Sep 20172:01 pmRNSVoting Rights and Capital
14th Sep 20172:48 pmRNSDirector/PDMR Shareholding
14th Sep 20179:33 amRNSDirector/PDMR Shareholding
13th Sep 20174:03 pmRNSDirector/PDMR Shareholding
13th Sep 20177:01 amRNSBoard Change
13th Sep 20177:00 amRNSFinal Results
22nd Aug 20171:52 pmRNSNotification of Final Results
18th Aug 20171:11 pmRNSHolding(s) in Company
1st Aug 201712:21 pmRNSVoting Rights and Capital
3rd Jul 20177:00 amRNSVoting Rights and Capital
28th Jun 20179:44 amRNSDirector/PDMR Shareholding
21st Jun 20173:05 pmRNSHolding(s) in Company
16th Jun 20174:35 pmRNSPrice Monitoring Extension
1st Jun 201712:00 pmRNSVoting Rights and Capital
19th May 201711:56 amRNSHolding(s) in Company
18th May 20177:00 amRNSTrading Statement
4th May 20177:00 amRNSProperty Disposal
3rd May 20171:56 pmRNSHolding(s) in Company
2nd May 20172:21 pmRNSVoting Rights and Capital
3rd Apr 201711:33 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.